• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

改善长期抑郁症服务的卫生经济建模创新:在当地卫生社区的示范。

Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community.

机构信息

School of Health and Related Research, University of Sheffield, Sheffield, South Yorkshire, UK.

出版信息

BMC Health Serv Res. 2013 Apr 26;13:150. doi: 10.1186/1472-6963-13-150.

DOI:10.1186/1472-6963-13-150
PMID:23622353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3644496/
Abstract

BACKGROUND

The purpose of the analysis was to develop a health economic model to estimate the costs and health benefits of alternative National Health Service (NHS) service configurations for people with longer-term depression.

METHOD

Modelling methods were used to develop a conceptual and health economic model of the current configuration of services in Sheffield, England for people with longer-term depression. Data and assumptions were synthesised to estimate cost per Quality Adjusted Life Years (QALYs).

RESULTS

Three service changes were developed and resulted in increased QALYs at increased cost. Versus current care, the incremental cost-effectiveness ratio (ICER) for a self-referral service was £11,378 per QALY. The ICER was £2,227 per QALY for the dropout reduction service and £223 per QALY for an increase in non-therapy services. These results were robust when compared to current cost-effectiveness thresholds and accounting for uncertainty.

CONCLUSIONS

Cost-effective service improvements for longer-term depression have been identified. Also identified were limitations of the current evidence for the long term impact of services.

摘要

背景

本分析旨在开发一种健康经济模型,以评估英国国家医疗服务体系(NHS)不同服务方案对长期抑郁症患者的成本和健康效益。

方法

本研究采用建模方法,开发了英格兰谢菲尔德长期抑郁症患者现有服务配置的概念性和健康经济模型。综合数据和假设,以估计每质量调整生命年(QALY)的成本。

结果

开发了三种服务变更,结果显示成本增加但 QALYs 增加。与现行护理相比,自我转诊服务的增量成本效益比(ICER)为每 QALY11378 英镑。减少辍学服务的 ICER 为每 QALY2227 英镑,非治疗服务增加 223 英镑。与当前的成本效益阈值进行比较并考虑不确定性时,这些结果是稳健的。

结论

确定了针对长期抑郁症的具有成本效益的服务改进。同时也发现了当前服务对长期影响证据的局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/3644496/23746c0c2b7a/1472-6963-13-150-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/3644496/7e2a61557d9c/1472-6963-13-150-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/3644496/ee4e8b19a9e3/1472-6963-13-150-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/3644496/23746c0c2b7a/1472-6963-13-150-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/3644496/7e2a61557d9c/1472-6963-13-150-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/3644496/ee4e8b19a9e3/1472-6963-13-150-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5d/3644496/23746c0c2b7a/1472-6963-13-150-3.jpg

相似文献

1
Innovation in health economic modelling of service improvements for longer-term depression: demonstration in a local health community.改善长期抑郁症服务的卫生经济建模创新:在当地卫生社区的示范。
BMC Health Serv Res. 2013 Apr 26;13:150. doi: 10.1186/1472-6963-13-150.
2
More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England.更频繁意味着成本更高?英国青光眼患者监测的卫生经济模型分析
BMC Health Serv Res. 2016 Oct 22;16(1):611. doi: 10.1186/s12913-016-1849-9.
3
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
4
Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.2 型糖尿病且未使用胰岛素的患者自我血糖监测(SMBG)的成本效益:建模假设对最近加拿大研究结果的影响。
Appl Health Econ Health Policy. 2011 Nov 1;9(6):351-65. doi: 10.2165/11594270-000000000-00000.
5
Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.通过社区药店为开始长期用药的患者提供支持的成本效益:新药物服务(NMS)与常规实践的经济评估比较。
Pharmacoeconomics. 2017 Dec;35(12):1237-1255. doi: 10.1007/s40273-017-0554-9.
6
Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis.针对既往接受过生物疗法的重度银屑病患者的生物治疗:一项成本效益分析。
Pharmacoeconomics. 2015 Feb;33(2):163-77. doi: 10.1007/s40273-014-0226-y.
7
A comparative analysis of models used to evaluate the cost-effectiveness of dabigatran versus warfarin for the prevention of stroke in atrial fibrillation.比较分析用于评估达比加群酯与华法林预防房颤卒中的成本效益的模型。
Pharmacoeconomics. 2013 Jul;31(7):589-604. doi: 10.1007/s40273-013-0035-8.
8
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.心脏再同步治疗(双心室起搏)用于心力衰竭的临床疗效及成本效益:系统评价与经济学模型
Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. doi: 10.3310/hta11470.
9
Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.协作式照护(与常规照护相比)对伴有抑郁症及共病糖尿病或心血管疾病患者的长期成本效益:一项基于COINCIDE随机对照试验的马尔可夫模型研究
BMJ Open. 2016 Oct 7;6(10):e012514. doi: 10.1136/bmjopen-2016-012514.
10
A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip.对微创全髋关节置换术治疗髋关节炎性疾病的临床有效性、成本效益及经济模型的系统评价。
Health Technol Assess. 2008 Jun;12(26):iii-iv, ix-223. doi: 10.3310/hta12260.

引用本文的文献

1
Modelling diabetes and depression in Pakistan: using economic modelling to inform intervention design and a clinical trial of a behavioural activation intervention.巴基斯坦糖尿病与抑郁症的模型构建:运用经济模型为干预设计提供信息及一项行为激活干预的临床试验
BMJ Open. 2025 May 19;15(5):e092158. doi: 10.1136/bmjopen-2024-092158.
2
Appraisal of patient-level health economic models of severe mental illness: systematic review.严重精神疾病患者层面健康经济模型评估:系统评价
Br J Psychiatry. 2021 Aug 19;220(2):1-12. doi: 10.1192/bjp.2021.121.
3
Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review.

本文引用的文献

1
Cost-effectiveness of an improving access to psychological therapies service.改善心理治疗服务可及性的成本效益。
Br J Psychiatry. 2013 Mar;202(3):220-7. doi: 10.1192/bjp.bp.111.107888. Epub 2013 Jan 10.
2
Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework.整体疾病建模以告知癌症资源分配决策:一种方法学框架。
Value Health. 2012 Dec;15(8):1127-36. doi: 10.1016/j.jval.2012.07.008. Epub 2012 Oct 25.
3
Cost-effectiveness of problem-solving treatment in comparison with usual care for primary care patients with mental health problems: a randomized trial.
基于模型的抑郁症治疗经济评估:系统文献综述
Pharmacoecon Open. 2017 Sep;1(3):149-165. doi: 10.1007/s41669-017-0014-7.
4
Replicating Health Economic Models: Firm Foundations or a House of Cards?复制健康经济模型:坚实基础还是纸牌屋?
Pharmacoeconomics. 2017 Nov;35(11):1113-1121. doi: 10.1007/s40273-017-0553-x.
5
The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation.英格兰用于识别抑郁症并为糖尿病患者提供治疗的护理路径变更的成本效益:基于模型的经济评估
BMC Health Serv Res. 2017 Jan 24;17(1):78. doi: 10.1186/s12913-017-2003-z.
6
Squaring the circle: a priority-setting method for evidence-based service development, reconciling research with multiple stakeholder views.化圆为方:一种基于证据的服务开发的优先级设定方法,协调研究与多个利益相关者的观点。
BMC Health Serv Res. 2015 Aug 12;15:320. doi: 10.1186/s12913-015-0958-1.
7
Resource modelling: the missing piece of the HTA jigsaw?资源建模:卫生技术评估拼图中缺失的一块?
Pharmacoeconomics. 2015 Mar;33(3):193-203. doi: 10.1007/s40273-014-0228-9.
解决问题治疗与常规护理相比在初级保健心理健康问题患者中的成本效益:一项随机试验。
BMC Fam Pract. 2012 Oct 10;13:98. doi: 10.1186/1471-2296-13-98.
4
Interventions to increase attendance at psychotherapy: a meta-analysis of randomized controlled trials.增加心理治疗参与度的干预措施:随机对照试验的荟萃分析。
J Consult Clin Psychol. 2012 Oct;80(5):928-39. doi: 10.1037/a0029630. Epub 2012 Aug 13.
5
Cost-effectiveness of nurse-led self-help for recurrent depression in the primary care setting: design of a pragmatic randomised controlled trial.在初级保健环境中,护士主导的自助治疗复发性抑郁症的成本效益:一项实用随机对照试验的设计。
BMC Psychiatry. 2012 Jun 7;12:59. doi: 10.1186/1471-244X-12-59.
6
Cost-effectiveness of family psychoeducation to prevent relapse in major depression: results from a randomized controlled trial.家庭心理教育预防重性抑郁复发的成本效益:一项随机对照试验的结果。
BMC Psychiatry. 2012 May 14;12:40. doi: 10.1186/1471-244X-12-40.
7
A critical review of model-based economic studies of depression: modelling techniques, model structure and data sources.抑郁的基于模型的经济学研究的批判性回顾:建模技术、模型结构和数据源。
Pharmacoeconomics. 2012 Jun 1;30(6):461-82. doi: 10.2165/11590500-000000000-00000.
8
Methodologies used in cost-effectiveness models for evaluating treatments in major depressive disorder: a systematic review.评估重度抑郁症治疗方法的成本效益模型中使用的方法:系统评价。
Cost Eff Resour Alloc. 2012 Feb 1;10(1):1. doi: 10.1186/1478-7547-10-1.
9
Cost utility of behavioural activation delivered by the non-specialist.非专业人员实施行为激活的成本效用。
Br J Psychiatry. 2011 Dec;199(6):510-1. doi: 10.1192/bjp.bp.110.090266. Epub 2011 Sep 22.
10
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis.12种新一代抗抑郁药的疗效与可接受性比较:一项多治疗组元分析
Lancet. 2009 Feb 28;373(9665):746-58. doi: 10.1016/S0140-6736(09)60046-5.